Skip to main content

Durahist

NDC 50991-865 · Poly Pharmaceuticals, Inc.

Generic nameDexbrompheniramine Maleate, Pseudoephedrine HCL
Dosage formTABLET
RouteORAL
Active ingredient(s)PSEUDOEPHEDRINE HYDROCHLORIDE, DEXBROMPHENIRAMINE MALEATE
Strength2; 60 mg/1; mg/1
Pharmacologic classAdrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

50991-865-02 — 12 TABLET in 1 BLISTER PACK (50991-865-02)

50991-865-90 — 90 TABLET in 1 BOTTLE, PLASTIC (50991-865-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50580-719 — Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, 50580-728 — Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, 50844-112 — Pseudoephedrine HCl, 50991-142 — Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide and Pseudoephedrine Hydrochloride, 50991-212 — Guaifenesin and Pseudoephedrine HCl, 50991-214 — Dextromethorphan HBr, Guaifenesin and Pseudoephedrine HCl, 50991-535 — ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PSEUDOEPHEDRINE HCl, 50991-540 — Codeine Phosphate, Dexbrompheniramine Maleate, 50991-783 — Dexbrompheniramine Maleate, 50991-788 — Dexbrompheniramine Maleate, Phenylephrine Hydrochloride, 51316-007 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 51316-015 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 51316-018 — Fexofenadine HCl and Pseudoephedrine HCl, 51316-121 — Pseudoephedrine HCl, 51316-317 — Pseudoephedrine Hydrochloride, 51316-339 — Naproxen sodium, Pseudoephedrine hydrochloride, 51316-345 — guaifenesin, pseudoephedrine hydrochloride, 51316-607 — Cetirizine hydrochloride, Pseudoephedrine hydrochloride, 51316-616 — Pseudoephedrine Hydrochloride, 51316-878 — guaifenesin and pseudoephedrine hydrochloride, +292 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels